$ARRY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARRAY BIOPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARRAY BIOPHARMA INC. Get notifications about new insider transactions in ARRAY BIOPHARMA INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Director | Sell | D | 48.00 | 24,297 | 1,166,256 | 5,000 | 29.3 K to 5 K (-82.93 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 15.97 | 678,750 | 10,839,638 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 10.92 | 600,000 | 6,552,000 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 8.79 | 421,875 | 3,708,281 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 3.00 | 453,750 | 1,361,250 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 7.30 | 113,438 | 828,097 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 4.63 | 345,312 | 1,598,795 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | D | 3.61 | 545,820 | 1,970,410 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | D | 0.00 | 442,190 | 0 | 0 | 442.2 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | D | 48.00 | 259,891 | 12,474,768 | 442,190 | 702.1 K to 442.2 K (-37.02 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Option Exercise | D | 8.70 | 25,000 | 217,500 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Sell | D | 48.00 | 5,000 | 240,000 | 5,000 | 10 K to 5 K (-50.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | D | 15.97 | 289,500 | 4,623,315 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | D | 10.92 | 289,500 | 3,161,340 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | D | 8.79 | 270,828 | 2,380,578 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | D | 3.00 | 187,500 | 562,500 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | D | 7.30 | 87,500 | 638,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | D | 0.00 | 114,821 | 0 | 0 | 114.8 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | D | 48.00 | 209,543 | 10,058,064 | 114,821 | 324.4 K to 114.8 K (-64.60 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | D | 15.97 | 138,000 | 2,203,860 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | D | 10.92 | 168,000 | 1,834,560 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | D | 8.79 | 131,250 | 1,153,688 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | D | 3.00 | 82,500 | 247,500 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | D | 7.30 | 165,000 | 1,204,500 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Sell | D | 0.00 | 61,813 | 0 | 0 | 61.8 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Sell | D | 48.00 | 150,190 | 7,209,120 | 61,813 | 212 K to 61.8 K (-70.84 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 15.97 | 315,750 | 5,042,528 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 10.92 | 335,250 | 3,660,930 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 8.79 | 313,989 | 2,759,963 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 3.00 | 236,250 | 708,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 7.30 | 236,250 | 1,724,625 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | D | 8.20 | 12,500 | 102,500 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Sell | D | 0.00 | 130,542 | 0 | 0 | 130.5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Sell | D | 48.00 | 71,022 | 3,409,056 | 130,542 | 201.6 K to 130.5 K (-35.24 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 5.95 | 25,000 | 148,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 5.13 | 25,000 | 128,250 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 3.87 | 25,000 | 96,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 5.60 | 25,000 | 140,000 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Option Exercise | D | 4.51 | 20,000 | 90,200 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Orwin John A | Director | Sell | D | 48.00 | 15,000 | 720,000 | 5,000 | 20 K to 5 K (-75.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | D | 48.00 | 30,000 | 1,440,000 | 0 | 30 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | U | 48.00 | 15,000 | 720,000 | 30,000 | 45 K to 30 K (-33.33 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | U | 48.00 | 20,000 | 960,000 | 45,000 | 65 K to 45 K (-30.77 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | D | 0.00 | 5,000 | 0 | 65,000 | 70 K to 65 K (-7.14 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | D | 48.00 | 85 | 4,080 | 70,000 | 70.1 K to 70 K (-0.12 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | U | 48.00 | 22,635 | 1,086,480 | 70,085 | 92.7 K to 70.1 K (-24.41 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 15.97 | 157,500 | 2,515,275 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 10.92 | 168,000 | 1,834,560 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 8.79 | 105,302 | 925,605 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 3.77 | 404,450 | 1,524,777 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | D | 0.00 | 56,026 | 0 | 0 | 56 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | D | 48.00 | 30,059 | 1,442,832 | 56,026 | 86.1 K to 56 K (-34.92 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.95 | 25,000 | 148,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.13 | 25,000 | 128,250 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 3.87 | 25,000 | 96,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.60 | 25,000 | 140,000 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 4.36 | 20,000 | 87,200 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 2.60 | 20,000 | 52,000 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Sell | D | 48.00 | 15,000 | 720,000 | 5,000 | 20 K to 5 K (-75.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Option Exercise | D | 14.93 | 25,000 | 373,250 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Sell | D | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Director | Sell | D | 48.00 | 8,000 | 384,000 | 10,000 | 18 K to 10 K (-44.44 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | BAUM CHARLES M | Director | Sell | U | 48.00 | 15,000 | 720,000 | 5,000 | 20 K to 5 K (-75.00 %) |
| Jun 06 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 7.30 | 100,000 | 730,000 | 87,500 | |
| Jun 06 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | S | 28.51 | 100,000 | 2,851,000 | 209,543 | 309.5 K to 209.5 K (-32.31 %) |
| Jun 06 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 7.30 | 100,000 | 730,000 | 309,543 | 209.5 K to 309.5 K (+47.72 %) |
| Jun 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 3.65 | 36,134 | 131,889 | 0 | |
| Jun 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 3.65 | 15,728 | 57,407 | 36,134 | |
| Jun 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | S | 27.58 | 36,134 | 996,738 | 209,543 | 245.7 K to 209.5 K (-14.71 %) |
| Jun 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 3.65 | 36,134 | 131,889 | 245,677 | 209.5 K to 245.7 K (+17.24 %) |
| Jun 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | S | 27.50 | 15,728 | 432,520 | 209,543 | 225.3 K to 209.5 K (-6.98 %) |
| Jun 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 3.65 | 15,728 | 57,407 | 225,271 | 209.5 K to 225.3 K (+7.51 %) |
| May 28 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 3.65 | 46,766 | 170,696 | 51,862 | |
| May 28 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 3.65 | 40,634 | 148,314 | 98,628 | |
| May 28 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | S | 27.00 | 74,915 | 2,022,930 | 209,543 | 284.5 K to 209.5 K (-26.34 %) |
| May 28 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 3.65 | 46,766 | 170,696 | 284,458 | 237.7 K to 284.5 K (+19.68 %) |
| May 28 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | S | 26.50 | 40,634 | 1,076,846 | 237,692 | 278.3 K to 237.7 K (-14.60 %) |
| May 28 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 3.65 | 40,634 | 148,314 | 278,326 | 237.7 K to 278.3 K (+17.10 %) |
| May 23 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 3.65 | 12,600 | 45,990 | 139,262 | |
| May 23 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | S | 26.50 | 12,600 | 333,900 | 237,692 | 250.3 K to 237.7 K (-5.03 %) |
| May 23 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 3.65 | 12,600 | 45,990 | 250,292 | 237.7 K to 250.3 K (+5.30 %) |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 0.00 | 9,844 | 0 | 9,844 | |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 0.00 | 9,844 | 0 | 0 | |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Payment of Exercise | F | 24.60 | 8,660 | 213,036 | 71,022 | 79.7 K to 71 K (-10.87 %) |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Buy | M | 0.00 | 19,688 | 0 | 79,682 | 60 K to 79.7 K (+32.82 %) |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 0.00 | 18,906 | 0 | 18,907 | |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 0.00 | 18,907 | 0 | 0 | |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Payment of Exercise | F | 24.60 | 16,631 | 409,123 | 259,891 | 276.5 K to 259.9 K (-6.01 %) |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 0.00 | 37,813 | 0 | 276,522 | 238.7 K to 276.5 K (+15.84 %) |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | M | 0.00 | 6,875 | 0 | 6,875 | |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | M | 0.00 | 6,875 | 0 | 0 | |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Payment of Exercise | F | 24.60 | 6,048 | 148,781 | 150,190 | 156.2 K to 150.2 K (-3.87 %) |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Buy | M | 0.00 | 13,750 | 0 | 156,238 | 142.5 K to 156.2 K (+9.65 %) |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 7,813 | 0 | 7,813 | |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 7,813 | 0 | 0 | |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Payment of Exercise | F | 24.60 | 6,932 | 170,527 | 237,692 | 244.6 K to 237.7 K (-2.83 %) |
| Apr 03 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 0.00 | 15,626 | 0 | 244,624 | 229 K to 244.6 K (+6.82 %) |
| Feb 21 2019 | ARRY | ARRAY BIOPHARMA IN ... | COX CARRIE SMITH | Buy | P | 23.20 | 5,000 | 115,998 | 8,000 | 3 K to 8 K (+166.67 %) | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Option Exercise | M | 10.47 | 25,000 | 261,750 | 0 | ||
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Sell | S | 20.85 | 5,000 | 104,261 | 20,000 | 25 K to 20 K (-20.00 %) | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Sell | S | 20.82 | 5,000 | 104,121 | 25,000 | 30 K to 25 K (-16.67 %) | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Sell | S | 20.51 | 25,000 | 512,693 | 22,720 | 47.7 K to 22.7 K (-52.39 %) | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Buy | M | 10.47 | 25,000 | 261,750 | 47,720 | 22.7 K to 47.7 K (+110.04 %) | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 4.63 | 87,500 | 405,125 | 0 | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 8.20 | 37,500 | 307,500 | 12,500 | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Sell | S | 20.03 | 239,626 | 4,798,511 | 59,994 | 299.6 K to 60 K (-79.98 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Buy | M | 4.63 | 87,500 | 405,125 | 299,620 | 212.1 K to 299.6 K (+41.25 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Buy | M | 8.20 | 37,500 | 307,500 | 212,120 | 174.6 K to 212.1 K (+21.48 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | M | 3.77 | 85,000 | 320,450 | 404,450 | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | S | 22.05 | 85,000 | 1,874,301 | 30,059 | 115.1 K to 30.1 K (-73.88 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Buy | M | 3.77 | 85,000 | 320,450 | 115,059 | 30.1 K to 115.1 K (+282.78 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | S | 20.00 | 11,712 | 234,240 | 30,059 | 41.8 K to 30.1 K (-28.04 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | M | 3.00 | 82,500 | 247,500 | 82,500 | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | M | 4.20 | 104,764 | 440,009 | 0 | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Sell | S | 21.58 | 187,264 | 4,041,756 | 142,488 | 329.8 K to 142.5 K (-56.79 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Buy | M | 4.20 | 104,764 | 440,009 | 329,752 | 225 K to 329.8 K (+46.56 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Buy | M | 3.00 | 82,500 | 247,500 | 224,988 | 142.5 K to 225 K (+57.90 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 3.61 | 110,000 | 397,100 | 545,820 | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | S | 21.64 | 110,000 | 2,380,015 | 238,709 | 348.7 K to 238.7 K (-31.54 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 3.61 | 110,000 | 397,100 | 348,709 | 238.7 K to 348.7 K (+46.08 %) |
| Feb 07 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | M | 8.94 | 40,000 | 357,600 | 363,900 | |
| Feb 07 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Sell | S | 20.00 | 40,000 | 800,000 | 15,021 | 55 K to 15 K (-72.70 %) |
| Feb 07 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Buy | M | 8.94 | 40,000 | 357,600 | 55,021 | 15 K to 55 K (+266.29 %) |
| Feb 07 2019 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Buy | M | 8.94 | 11,100 | 99,234 | 15,021 | 3.9 K to 15 K (+283.09 %) |
| Feb 04 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | M | 4.20 | 95,236 | 399,991 | 104,764 | |
| Feb 04 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Payment of Exercise | F | 18.67 | 21,425 | 400,005 | 142,488 | 163.9 K to 142.5 K (-13.07 %) |
| Feb 04 2019 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Buy | M | 4.20 | 95,236 | 399,991 | 163,913 | 68.7 K to 163.9 K (+138.67 %) |
| Feb 01 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 7.30 | 113,438 | 828,097 | 113,438 | |
| Feb 01 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 3.61 | 100,000 | 361,000 | 655,820 | |
| Feb 01 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | S | 18.53 | 113,438 | 2,101,541 | 238,709 | 352.1 K to 238.7 K (-32.21 %) |
| Feb 01 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 7.30 | 113,438 | 828,097 | 352,147 | 238.7 K to 352.1 K (+47.52 %) |
| Feb 01 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | S | 18.25 | 100,000 | 1,825,370 | 238,709 | 338.7 K to 238.7 K (-29.52 %) |
| Feb 01 2019 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 3.61 | 100,000 | 361,000 | 338,709 | 238.7 K to 338.7 K (+41.89 %) |